GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCHE, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FABP3, FABP4, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD11B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR7, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK |
15.7142 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, BCHE, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, PTGS2 |
14.8646 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, BCHE, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, PTGS2 |
14.8646 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCHE, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
14.2677 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCHE, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
14.1986 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
12.9184 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
12.9134 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, BCHE, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, GRIK5, GRM5, HSD11B2, HTR5A, IGF1R, INSR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SRC, TEK |
12.4836 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALOX15, ALPL, APP, BCHE, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, GRIK5, GRM5, HSD11B2, HSPA1A, HTR5A, IGF1R, INSR, KDR, MMP2, PIK3CA, PPARA, PTGS2, SMAD3, SRC, TEK |
12.4642 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8, HTR2A, PTGS2 |
12.2948 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR6, HTR7 |
12.2867 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALOX15, ALPL, APP, BCHE, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, GRIK5, GRM5, HSD11B2, HSPA1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SMAD3, SRC, TEK |
12.0864 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, INSR, MET, PIK3CA, PIK3CB, SMAD3 |
11.9897 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CYP1B1, DRD2, EGFR, F10, F3, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
11.7065 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
11.1991 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
10.9018 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
10.8212 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, BCHE, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, FABP3, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTGS1, PTGS2, SMAD3, SRC, TEK |
10.8016 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
10.8016 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
10.5862 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CNR1, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR7 |
10.5862 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC |
10.2682 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, APP, CA2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, INSR, PIK3CA, PIK3CB, SIGMAR1, SRC |
9.95759 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, APP, BCHE, BCL2, CA2, CA9, CSNK2A1, DRD1, EGFR, ESR1, FABP3, GRM5, HSD11B2, HTR5A, IGF1R, INSR, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
9.89782 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, APP, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, GRIK5, GRM5, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
9.89507 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX15, ALPL, APP, BCHE, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FABP4, GRM1, GRM5, GRM8, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SMAD3, SRC, TEK |
9.87407 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR7 |
9.71339 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, APP, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FABP4, GRM1, GRM3, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
9.35126 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FABP4, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
9.24812 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, GPR35, GRIK5, GRM1, GRM5, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
9.10462 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, EGFR, FABP3, GRM1, GRM5, HTR2A, HTR2B, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.92955 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, EGFR, FABP3, GRM1, GRM5, HTR2A, HTR2B, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.92955 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, APP, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, GPR35, GRM1, GRM3, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.87986 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCHE, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, HSD11B2, HTR5A, PTGS2, SRC, TEK |
8.77563 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, BCHE, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HSD11B2, HTR2A, HTR2B, KDR, PTGS2, SRC |
8.68313 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALPL, APP, BCHE, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FABP3, FABP4, GRIK5, GRM1, GRM5, HSD11B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.68313 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.58427 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, APP, BCHE, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, INSR, PIK3CA, PTGS2, SRC, TEK |
8.53893 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
8.46236 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTPN1, SIGMAR1, SMAD3, SRC, TEK |
8.3574 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
8.34846 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SLC1A1, SMAD3, SRC, TEK |
8.34422 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
8.16321 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, BCHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRIK5, HTR1A, INSR, PTGS2, SLC1A1, SMAD3 |
8.14984 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.12171 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
8.11187 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD2 |
7.94069 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
7.93275 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.92109 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
7.88016 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, GRM1, GRM5, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
7.8718 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, GRM1, GRM5, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TEK |
7.86867 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, PIK3CA, PIK3CB, SMAD3 |
7.77851 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, GRM1, GRM5, HTR2A, HTR2B, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
7.75649 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, BCHE, BCL2, CA2, CA9, CSNK2A1, EGFR, ESR1, FABP3, HSD11B2, HTR5A, INSR, PPARA, PTGS2, SRC, TEK |
7.73178 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP4, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.72604 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
7.69175 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, BCHE, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, FABP3, GRM5, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK |
7.66233 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, GRM1, GRM5, HTR2A, HTR2B, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
7.44092 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
7.4223 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
7.4223 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, APP, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, GRIK5, GRM5, HSPA1A, HTR1A, HTR2A, HTR2B, INSR, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC |
7.4223 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, BCHE, CNR2, DRD1, DRD2, HTR2A, PTGS2 |
7.4223 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
7.41211 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.41211 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.40286 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, GRM1, HSD11B2, HSPA1A, HTR2A, HTR2B, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
7.3754 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.27553 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
7.23838 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.22522 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CNR1, DRD1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1, TEK |
7.22522 |
[BP] GO:0007610 |
None
|
APP, BCHE, BCL2, CNR1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, HTR1A, HTR2A, HTR2B, INSR, PPARA, PTGS2 |
7.22522 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
7.21057 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
7.207 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, BCHE, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, FABP3, GRM5, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK |
7.19111 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, CNR1, DRD2, DRD3, HSD11B2, PPARA, PTGS1, PTGS2, SMAD3 |
7.12199 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
7.10078 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.10078 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.10078 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.10078 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.10044 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, BCHE, BCL2, CNR2, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC |
7.08885 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CNR1, DRD1, DRD2, DRD3, EGFR, HTR2A, HTR2B, KDR, PIK3CB, PTGS2, SRC |
7.07684 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
7.07434 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, BCHE, BCL2, CNR2, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC |
7.07434 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, APP, BCL2, CNR1, CNR2, DRD1, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
7.05271 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
7.05138 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
7.00035 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.99191 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.94608 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, CSNK2A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
6.94608 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
DRD2, DRD3, EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
6.93704 |
[BP] GO:0050890 |
None
|
ADORA1, APP, BCHE, CNR1, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2A, INSR, PTGS2 |
6.91855 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.90878 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, APP, DRD2, DUSP3, EGFR, HTR2A, HTR2B, KDR, PTPN1, SRC, TEK |
6.88944 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, BCL2, CNR1, DRD1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, PTGS2, SLC1A1, TEK |
6.88332 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
6.88332 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, PTGS2, TEK |
6.75758 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, PIK3CA, PIK3CB, SMAD3 |
6.72414 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
6.72414 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, APP, DRD2, EGFR, GRM1, HTR2A, HTR2B, INSR, KDR, PIK3CB, PTPN1, SRC, TEK |
6.71101 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ALOX15, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.68334 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CNR1, DRD1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1, TEK |
6.65168 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.64926 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.64926 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
6.61934 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
6.61934 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, GRIK5, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK |
6.58918 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, GRIK5, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK |
6.51975 |
[BP] GO:0007611 |
None
|
APP, BCHE, CNR1, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2A, INSR, PTGS2 |
6.5171 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, APP, DRD2, DUSP3, EGFR, GRM1, HTR2A, HTR2B, IGF1R, INSR, KDR, PIK3CB, PTPN1, SRC, TEK |
6.49877 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.43622 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.41019 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, FABP4, GPR35, GRM3, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SRC |
6.39751 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
6.3845 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
6.36016 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, CYP2A6, CYP2D6, ESR1, HSD11B1, HSD11B2 |
6.31148 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, GRM1, GRM5, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
6.27248 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, DRD3, GPR35, HTR2A, MMP9, PTGS2 |
6.21092 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
6.21092 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, BCL2, CSNK2A1, DRD2, EGFR, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
6.17733 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD2, EGFR, GRM1, GRM5, HTR2A, HTR2B, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
6.1546 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, APP, DRD2, EGFR, HTR2A, HTR2B, KDR, SRC, TEK |
6.1402 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
6.12264 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, PIK3CB, SMAD3 |
6.12264 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
6.12204 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, GRIK5, GRM5, IGF1R, INSR, KDR, MMP2, PIK3CA, PTGS2, SMAD3, SRC |
6.11795 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
6.10926 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PTGS2, SMAD3, SRC |
6.04034 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
6.00129 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
5.99983 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, KDR, MET, PPARA, PTGS2, SMAD3, TEK |
5.99969 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.99969 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.99969 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.9929 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
5.97137 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, GRM1, GRM5, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
5.96088 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, GRIK5, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK |
5.95674 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HSD11B1, HSD11B2, HTR1A, HTR2A |
5.89902 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CNR1, DRD1, DRD2, DRD3, GPR35, GRM5, HTR1A, HTR2A, MMP9, PTGS2 |
5.81559 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.72527 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCHE, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, EGFR, ESR1, FABP3, HSD11B2, HTR5A, PTGS2, SRC |
5.69162 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.65341 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.6332 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.57977 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, GRM1, GRM5, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.51589 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CNR1, CNR2, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.4985 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.48808 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, EGFR, ESR1, ESR2, F3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, INSR, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
5.47592 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.41754 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
5.39693 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.39004 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, FABP3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.36101 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, BCHE, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
5.34147 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.31041 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, ESR1, GRM5, HTR2A, HTR2B |
5.2463 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, SRC |
5.22878 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.21316 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.20096 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.19178 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, GRM1, GRM5, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.19178 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, APP, BCHE, BCL2, CA2, CA9, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FUT7, HSD11B1, HTR2A, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SIGMAR1, SMAD3, SRC, TEK |
5.18755 |
[BP] GO:0007612 |
None
|
APP, BCHE, DRD1, DRD2, DRD3, GRM5, INSR, PTGS2 |
5.16932 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, FABP3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.15473 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A |
5.11147 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, BCHE, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, GRM3, GRM8, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.10768 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
5.05979 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, GRM1, HTR2A, HTR2B, IGF1R, INSR, PIK3CB, PTPN1, SRC |
5.03214 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.02102 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, GRM1, GRM5, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
5.00304 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, HSPA1A, HTR2B, PIK3CA, PPARA, PTGS1, PTGS2 |
4.99394 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC |
4.97795 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
4.92802 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.87856 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, BCHE, CYP1A1, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A |
4.87856 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, APP, BCHE, BCL2, CA12, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC1A1, SMAD3, SRC, TEK |
4.80799 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, SMAD3 |
4.77444 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
4.77444 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, FABP3, HTR2A, HTR2B, PPARA, PTGS2, SRC, TEK |
4.77444 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.7667 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.75587 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, APP, BCHE, BCL2, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK |
4.75289 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, CYP1B1, DRD1, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, PIK3CA, PTGS2, SRC |
4.70527 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.68571 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.6574 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.6574 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
4.64746 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, CNR1, DRD1, DRD2, DRD3, EGFR, PIK3CB, PTGS2 |
4.62646 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
4.62049 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, APP, BCHE, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, GRM3, GRM8, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.60423 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.58534 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.58534 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1A, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.5801 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, APP, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, F3, HSPA1A, HTR2A, HTR2B, KDR, MET, MMP9, PTGS2, SLC1A1, SMAD3, SRC, TEK |
4.56793 |
[BP] GO:0050877 |
None
|
ADORA1, APP, BCHE, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, HTR2A, INSR, PTGS2 |
4.54821 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.53763 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
BCHE, CYP1A1, CYP1B1, CYP2A13, CYP2D6, NQO2, PTGS1 |
4.53763 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIK3CA, PTGS2, PTPN1, SMAD3, SRC |
4.53058 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, SMAD3, TEK |
4.53058 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2B, HTR5A, KDR |
4.50695 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2 |
4.46533 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, CDC25B, DRD2, EGFR, GRM1, GRM5, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.45595 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA |
4.446 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CNR1, CSNK2A1, EGFR, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1, SMAD3 |
4.42466 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, DRD2, EGFR, FABP4, MMP9, PTGS2 |
4.38651 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3, HTR2A |
4.34158 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.34157 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, HTR2A, HTR2B, PPARA, PTGS2, SRC, TEK |
4.33711 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK |
4.2998 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A |
4.28438 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, DRD3, PPARA |
4.28345 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2 |
4.26367 |
[BP] GO:0015711 |
organic anion transport
|
CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC1A1 |
4.24502 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, SRC, TEK |
4.23768 |
[BP] GO:0016477 |
cell migration
|
CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
4.21057 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, DRD2, DRD3, EGFR, GPR35, GRM1, HTR2A, PTGS2, SLC1A1, SMAD3 |
4.18141 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, APP, BCHE, BCL2, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC1A1, SMAD3, SRC, TEK |
4.14734 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, EGFR, HTR2B, MET, PIK3CA, PPARA, SMAD3 |
4.14151 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC |
4.13279 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, GRM1, HTR2A, HTR2B, INSR, PIK3CB, PTPN1, SRC |
4.13099 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.09193 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.0598 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1B1, CYP2A13, CYP2A6 |
4.00928 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR2A, MET |
3.97672 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.97415 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, PPARA, SMAD3, TEK |
3.94621 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.91837 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, HTR7, PPARA, SRC |
3.88565 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ALOX15, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
3.86696 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, APP, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, GPR35, GRM1, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, MMP9, PIK3CA, PTGS2, SLC1A1, SMAD3, SRC, TEK |
3.85263 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, APP, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.85236 |
[BP] GO:0040011 |
locomotion
|
CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
3.83905 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
3.82667 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
3.81143 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.80296 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.78652 |
[BP] GO:0006811 |
None
|
ADRA1A, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, PPARA, SLC1A1 |
3.77999 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCHE, BCL2, CA2, EGFR, HSD11B2, PTGS2, SRC |
3.76616 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, BCL2, CNR1, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.759 |
[BP] GO:0048870 |
cell motility
|
CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
3.74908 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, APP, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.73188 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCHE, BCL2, EGFR, HSD11B2, PTGS2, SRC |
3.73188 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, HSD11B1, HTR5A, INSR, KDR, MMP9, PIK3CA, PPARA, PTGS2, SIGMAR1, SMAD3, SRC, TEK |
3.70989 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, EGFR, ESR1, HSD11B1, INSR, KDR, PIK3CA, PPARA, SMAD3, SRC, TEK |
3.69449 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, BCL2, CNR1, CNR2, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP4, GRM3, GRM8, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC |
3.68761 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
3.68507 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.66378 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.66378 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, SRC, TEK |
3.65867 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.6528 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.65228 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.65228 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, EGFR, GRM5, IGF1R, INSR, MMP2, PTGS2, SRC |
3.64779 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.62042 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, INSR, PTGS2 |
3.61099 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, APP, BCL2, CNR1, DRD2, DRD3, GPR35, HSPA1A, HTR2A, MMP9, PTGS2 |
3.60626 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8, HTR2A, INSR, PPARA |
3.58654 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, DRD2, EGFR, GRM1, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
3.58171 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB |
3.56923 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.55627 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, GRM1, HTR2A, HTR2B, IGF1R, INSR, PIK3CB, PTPN1, SRC |
3.55487 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR2A |
3.55024 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, BCL2, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, HTR2B, INSR, PTGS2, SMAD3, SRC |
3.52897 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.52641 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8, HTR2A, INSR, PPARA |
3.50368 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.49887 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, DRD2, PPARA, SMAD3, TEK |
3.49174 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.4657 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ALOX15, APP, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.44898 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
3.43935 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPR35, GRM1, HTR2A, HTR2B |
3.42187 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, PPARA, SMAD3, TEK |
3.40697 |
[BP] GO:0045777 |
None
|
ADORA1, ADRA1A, CNR1, HSD11B2 |
3.38579 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.38579 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, PIK3CA |
3.37604 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, EGFR, GRM5, IGF1R, INSR, MMP2, PTGS2, SRC |
3.37336 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.35936 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.33669 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
APP, CNR1, CNR2, CSNK2A1, DRD2, DRD3, DUSP3, FABP4, GRM3, IGF1R, MMP9, PTGS2, PTPN1, SRC |
3.29632 |
[BP] GO:1903524 |
None
|
ADRA1A, EGFR, HTR2A, PTGS2, SLC1A1 |
3.29207 |
[BP] GO:0045907 |
None
|
ADRA1A, EGFR, HTR2A, PTGS2 |
3.28686 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.27496 |
[BP] GO:0016310 |
phosphorylation
|
APP, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, SRC, TEK |
3.26786 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, GRM3, GRM8, PPARA |
3.26786 |
[BP] GO:0006820 |
anion transport
|
CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC1A1 |
3.26344 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.25077 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, PIK3CA |
3.24847 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD11B2, NQO2, PTGS1, PTGS2 |
3.24789 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, SRC, TEK |
3.24523 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, GRM3, GRM8, PPARA |
3.24523 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.24468 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.24468 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, GRM1, HTR2A, HTR2B, INSR, PIK3CB, PTPN1, SRC |
3.24468 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, PTGS2, SRC |
3.24468 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.23188 |
[BP] GO:0021885 |
forebrain cell migration
|
DRD1, DRD2, EGFR, HTR6 |
3.20179 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CYP1B1, DUSP3, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
3.17863 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, SRC, TEK |
3.14732 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX15, ALPL, APP, BCHE, BCL2, CA12, CA2, CA4, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC1A1, SMAD3, SRC, TEK |
3.14451 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
3.14173 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC |
3.14043 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
3.135 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
ADRA1A, APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, HTR2A, HTR2B, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC |
3.12574 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.11973 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HTR1A, HTR2A, HTR2B, SRC |
3.10579 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, EGFR, ESR1, GRM5, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC |
3.10061 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F3, FABP4, KDR, MET, PTGS2, SMAD3 |
3.09921 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.07169 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
3.0716 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.0691 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CNR1, DRD2, DRD3, EGFR, HTR2B, PTGS2, PTPN1, SMAD3, SRC |
3.05373 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, APP, BCHE, BCL2, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.046 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, DRD2, EGFR, HTR2A, PTGS2, SLC1A1 |
3.04499 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.04386 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.04386 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, HSD11B2, INSR, MMP2, MMP9, PTGS2, SRC |
3.0365 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA1A, ALOX15, APP, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.0193 |
[BP] GO:0032787 |
None
|
ALOX15, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
3.01158 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, BCHE, CYP1A1, EGFR, PTGS2 |
3.00985 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCHE, BCL2, EGFR, HSD11B2, PTGS2 |
3.00521 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, BCHE, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, PTGS2, SMAD3 |
2.99986 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.98972 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, BCL2, CNR1, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, GRIK5, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PTPN1, SMAD3, SRC, TEK |
2.98505 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.96382 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.96382 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, DUSP3, ESR1, HSPA1A, MMP2, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC |
2.9556 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.9556 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.9556 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.9556 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
2.94683 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, PIK3CA |
2.94654 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK |
2.94461 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
2.9343 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, SRC |
2.9343 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, DRD3, EGFR |
2.90147 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.89436 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.89436 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, EGFR, FABP4, MMP9, PTGS2 |
2.87153 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.87153 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.85842 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.85842 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, BCL2, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.84288 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, GRIK5, HTR1A |
2.84102 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HTR1A, HTR2A, HTR2B, SRC |
2.84102 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.82341 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.8213 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCHE, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC |
2.8213 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.7949 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.7949 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.79298 |
[BP] GO:0022898 |
None
|
APP, BCL2, DRD2, DRD3, GPR35, GRM5, MMP9 |
2.79298 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, GRM5, PTGS2 |
2.7904 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, GRM5, HTR2A, PTPN1, SRC |
2.76001 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, DRD3, HTR2A |
2.76001 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.73187 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.7265 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.7265 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, BCHE, EGFR, FABP3, KDR, MMP2, PTGS2, SRC |
2.71886 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.69377 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.69377 |
[BP] GO:0030817 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8 |
2.6828 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, PIK3CA, PTGS2 |
2.6626 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.6618 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.65846 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.65846 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.65846 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.65846 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.65846 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.65391 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3 |
2.65391 |
[BP] GO:0032409 |
None
|
APP, BCL2, DRD2, DRD3, GPR35, GRM5, MMP9 |
2.65391 |
[BP] GO:0040008 |
regulation of growth
|
APP, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIK3CA, SMAD3 |
2.64398 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.63961 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.63961 |
[BP] GO:0030260 |
entry into host cell
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.63961 |
[BP] GO:0044409 |
entry into host
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.63961 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, BCHE, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC |
2.63961 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.61347 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB |
2.61347 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
BCL2, CNR1, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1 |
2.60647 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3 |
2.60102 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.60102 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.60102 |
[BP] GO:0034762 |
None
|
APP, BCL2, CA2, DRD1, DRD2, DRD3, GPR35, GRM5, MMP9 |
2.59412 |
[BP] GO:0098900 |
None
|
ADRA1A, CNR1, CNR2, GPR35 |
2.59067 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.59067 |
[BP] GO:0019233 |
None
|
CNR1, CNR2, GRM1, PTGS2 |
2.59067 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, EGFR, FABP4, MMP9, PTGS2 |
2.56418 |
[BP] GO:0051098 |
regulation of binding
|
APP, BCL2, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC |
2.56309 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.56309 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.56309 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.54349 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.54349 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1B1, CYP2D6, EGFR |
2.54043 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, BCL2, CNR1, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, FABP4, GRM3, GRM8, HSPA1A, HTR2B, IGF1R, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC |
2.54039 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.53876 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.53876 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.52923 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1 |
2.52651 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.52651 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.50511 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.48841 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.48841 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.48841 |
[BP] GO:0007626 |
None
|
APP, DRD1, DRD2, DRD3, GRM1, GRM5 |
2.48724 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.48724 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.48724 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.47867 |
[BP] GO:0010959 |
None
|
ADORA1, BCL2, DRD1, DRD2, DRD3, GPR35, HTR2A, PTGS2 |
2.47867 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, BCHE, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FUT7, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
2.4784 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR2A |
2.46802 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.43292 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CNR1, DRD2, DRD3, EGFR, HTR2B, PTGS2, PTPN1, SMAD3, SRC |
2.42993 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.4108 |
[BP] GO:0019229 |
None
|
ADRA1A, EGFR, HTR2A, PTGS2 |
2.4108 |
[BP] GO:0030814 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8 |
2.39898 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2 |
2.38535 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.38535 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.38535 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.38535 |
[BP] GO:0030802 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8 |
2.35075 |
[BP] GO:0043434 |
None
|
FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK |
2.33228 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.3311 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, BCHE, CNR1, CYP1A1, EGFR, PTGS2 |
2.32813 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, APP, BCHE, BCL2, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FUT7, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK |
2.32371 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.31749 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, PTGS2 |
2.31333 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.31333 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.30594 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, CYP1B1, DRD1, EGFR, KDR, PTGS2, SRC |
2.30126 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
BCL2, DRD2, GPR35, PTGS2 |
2.28974 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.28588 |
[BP] GO:0048169 |
None
|
APP, DRD2, GRM5 |
2.28588 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HTR2B, SRC |
2.28522 |
[BP] GO:0009416 |
response to light stimulus
|
APP, BCL2, DRD1, DRD2, DRD3, EGFR, PTGS2 |
2.2769 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, GRIK5, MMP9, PIK3CB, PTGS2, SMAD3, SRC |
2.27488 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1B1, CYP2D6, EGFR |
2.26489 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.24494 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, GRIK5, MMP9, PIK3CB, PTGS2, SMAD3, SRC |
2.24334 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.24115 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.24115 |
[BP] GO:0045913 |
None
|
HTR2A, INSR, PPARA, SRC |
2.22325 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.22325 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.22325 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.22325 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.22325 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.22325 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.22325 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.22325 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.22325 |
[BP] GO:1900371 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8 |
2.21344 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, BCL2, MET, MMP9, PPARA, SRC |
2.21092 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.20955 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.20475 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC |
2.20475 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC |
2.20475 |
[BP] GO:0030808 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8 |
2.20475 |
[BP] GO:0060341 |
regulation of cellular localization
|
APP, BCL2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, GRIK5, PTGS2, PTPN1, SMAD3, SRC |
2.1955 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PTGS2, SMAD3, SRC |
2.19266 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.19226 |
[BP] GO:0033135 |
regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, PIK3CA, PTGS2 |
2.19225 |
[BP] GO:0050776 |
regulation of immune response
|
ALOX15, BCL2, CNR1, DRD2, DUSP3, ESR1, HSPA1A, MMP2, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC |
2.18746 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GRM5, IGF1R, INSR, SRC |
2.18746 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, BCL2, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, HTR2B, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.1826 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, BCL2, CNR1, CSNK2A1, DRD2, DRD3, EGFR, HTR2B, PTGS2, PTPN1, SMAD3, SRC |
2.17372 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3 |
2.17372 |
[BP] GO:0010507 |
negative regulation of autophagy
|
BCL2, HTR2B, MET, PIK3CA |
2.17372 |
[BP] GO:0051482 |
None
|
DRD1, GPR35, GRM1 |
2.16971 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.16971 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.16971 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, FABP3, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, PPARA, PTGS2, SMAD3, SRC |
2.16093 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.16056 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, DRD2, EGFR, HTR2B, PTGS2, SMAD3, SRC |
2.15645 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.15621 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
KDR, PIK3CA, PIK3CB, SRC |
2.15621 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.12839 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, HTR7, PPARA |
2.12839 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB |
2.1224 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.1224 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.1224 |
[BP] GO:0061097 |
None
|
ADORA1, APP, GRM5, PTPN1 |
2.1154 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, PIK3CB, SRC |
2.09549 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.0951 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.0951 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.0931 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.0931 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.0931 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.0931 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, DRD2, PIK3CB, PTPN1, SRC |
2.08654 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.08593 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.08593 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.08593 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.08593 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2 |
2.08593 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.08593 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.08237 |
[BP] GO:0051223 |
None
|
ACHE, APP, CNR1, DRD2, DRD3, EGFR, HTR2B, PTGS2, PTPN1, SMAD3, SRC |
2.06984 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, BCL2, CYP1A1, EGFR, ESR1, HTR1A, MET, PIK3CB, SRC, TEK |
2.06747 |
[BP] GO:0032412 |
None
|
APP, DRD2, DRD3, GPR35, GRM5, MMP9 |
2.06587 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.06587 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, DRD3 |
2.06587 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.06587 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.06587 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.06587 |
[BP] GO:0030799 |
None
|
DRD1, DRD2, DRD3, GRM3, GRM8 |
2.06587 |
[BP] GO:0050808 |
None
|
ACHE, APP, DRD1, DRD2, GRM5 |
2.05244 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, BCL2, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, SMAD3 |
2.04957 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, HSPA1A, MET, MMP1, SRC |
2.04054 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, F3, GRIK5, MMP9, PIK3CB, PTGS2, SMAD3, SRC |
2.04047 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, GRM3 |
2.0307 |
[BP] GO:0043278 |
None
|
CNR1, DRD2, DRD3 |
2.0307 |
[BP] GO:0014072 |
None
|
CNR1, DRD2, DRD3 |
2.0307 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.0307 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A |
2.0307 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, CA4, CNR1, CNR2, DRD1, DRD2, DRD3, F10, F3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC1A1, TEK |
11.9633 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ALOX15, APP, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTGS2, SIGMAR1, SLC1A1, SRC, TEK |
11.9061 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, APP, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC1A1, SRC, TEK |
10.7027 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, APP, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PTPN1, SLC1A1, SMAD3, SRC, TEK |
10.4237 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, APP, BCHE, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC1A1, SMAD3, SRC, TEK |
9.95759 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, CNR1, CNR2, DRD1, DRD2, DRD3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC1A1, TEK |
9.95759 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CNR1, DRD1, DRD2, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, INSR, MET, PTGS2, SIGMAR1, SLC1A1, SRC, TEK |
9.93397 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CNR1, CNR2, DRD1, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, SRC, TEK |
6.55397 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CNR1, CNR2, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, SRC, TEK |
6.28616 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, PTGS2, SRC |
5.93351 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, HTR5A, INSR, PTGS1, PTGS2, SIGMAR1, SRC |
5.1622 |
[CC] GO:0042734 |
None
|
CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.8036 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
4.68076 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
4.6574 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCHE, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, EGFR, F10, GRIA2, HSD11B1, HSD11B2, PTGS1, PTGS2, PTPN1, SIGMAR1 |
4.43516 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CNR1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SIGMAR1, SRC |
4.3874 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CNR1, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, INSR, PTGS1, SIGMAR1, SRC |
4.31905 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CNR1, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, INSR, PTGS1, SIGMAR1, SRC |
4.31905 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SIGMAR1, SRC |
4.06353 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SIGMAR1, SRC |
4.06353 |
[CC] GO:0098589 |
membrane region
|
ADRA1A, APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
4.0183 |
[CC] GO:0097060 |
None
|
CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SIGMAR1 |
3.85263 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, EGFR, GRIA2, HSD11B1, HSD11B2, PTGS1, PTGS2, SIGMAR1 |
3.74473 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, CA12, CA14, CA4, CA9, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F3, FUT7, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD11B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC1A1, TEK |
3.68507 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
3.50368 |
[CC] GO:0043197 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.35006 |
[CC] GO:0044309 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.31179 |
[CC] GO:0005901 |
caveola
|
ADRA1A, HTR2A, INSR, PTGS2, SRC |
3.26786 |
[CC] GO:0044853 |
plasma membrane raft
|
ADRA1A, HTR2A, INSR, PTGS2, SRC |
2.8213 |
[CC] GO:0098794 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
2.81728 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ALPL, APP, CA12, CA14, CA9, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FUT7, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD11B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC1A1, TEK |
2.7773 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.54349 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CYP19A1, CYP2D6, GRIK5, HSPA1A, HTR5A, KDR, PTGS2, PTPN1, SIGMAR1 |
2.49234 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.40872 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.08593 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, INSR, SRC |
2.06589 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, TEK |
14.1986 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
13.6495 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, TEK |
12.8388 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
12.6569 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
12.6569 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, SMAD3, TEK |
12.618 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SIGMAR1, TEK |
12.5775 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, BCHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
9.87461 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.44001 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
8.2638 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALPL, APP, BCHE, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, SMAD3, SRC, TEK |
8.14984 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.77373 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, SMAD3 |
7.66233 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, GPR35, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
7.55565 |
[MF] GO:0008144 |
drug binding
|
ACHE, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, SIGMAR1, SRC, TEK |
7.41211 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.10078 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.10078 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.10078 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.10078 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.9206 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, BCHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.66961 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, SRC |
6.54251 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, SRC |
6.28616 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
5.99969 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, APP, BCHE, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, NUAK1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, SMAD3 |
5.56826 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2D6 |
5.50272 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
5.11306 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.09589 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.8036 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
4.77444 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.69393 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, BCHE, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, F10, F3, FUT7, HSD11B1, HSD11B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SRC, TEK |
4.5801 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.37424 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.25639 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD11B2, NQO2, PTGS1, PTGS2 |
4.16846 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2D6 |
4.14489 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.82667 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B2, NQO2, PTGS1, PTGS2, SRC |
3.69453 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, SMAD3 |
3.67929 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.6558 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.49887 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.34491 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.135 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.06457 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.06457 |
[MF] GO:0003990 |
acetylcholinesterase activity
|
ACHE, BCHE |
3.06457 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
3.06457 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.06457 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
3.04386 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, IGF1R, INSR, NQO2 |
2.94683 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.65846 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.65846 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.65846 |
[MF] GO:0004104 |
cholinesterase activity
|
ACHE, BCHE |
2.65846 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.65846 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.60102 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.60102 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, HTR2A, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.56375 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.54349 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.42862 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.4108 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.4108 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.4108 |
[MF] GO:0001540 |
amyloid-beta binding
|
ACHE, BCHE, GRIA2, INSR |
2.4108 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, HTR2A, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.31333 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.26877 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.22325 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.22325 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.20955 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCHE, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, GRIK5, IGF1R, KDR, MET, MMP9, NQO2, PTGS2, SMAD3 |
2.20475 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.20475 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.1154 |
[MF] GO:0004672 |
protein kinase activity
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, SRC, TEK |
2.07135 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, SRC, TEK |
2.06587 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.06587 |